Lower IGFBP-1 and IGF-I serum concentrations were associated with an increased risk of IHD later in life or with higher cardiovascular disease mortality in men and women at an age between 51 and 98 years (28). The gene discussed is IGF1; the disease is cardiovascular disorder.